In 2024, Wize Pharma's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.

Wize Pharma Aktienanalyse

What does Wize Pharma do?

Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Wize Pharma's Return on Assets (ROA)

Wize Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Wize Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Wize Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Wize Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Wize Pharma stock

What is the Return on Assets (ROA) of Wize Pharma this year?

The Return on Assets (ROA) of Wize Pharma is 0 undefined this year.

What was the ROA of Wize Pharma compared to the previous year?

The ROA of Wize Pharma has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Wize Pharma?

A high ROA is advantageous for investors of Wize Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Wize Pharma?

A low ROA can be unfavorable for investors of Wize Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Wize Pharma affect the company?

An increase in ROA of Wize Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Wize Pharma impact the company?

A reduction in the ROA of Wize Pharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Wize Pharma?

Some factors that can influence the ROA of Wize Pharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Wize Pharma important for investors?

The ROA of Wize Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Wize Pharma take to improve ROA?

To improve ROA, Wize Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Wize Pharma pay?

Over the past 12 months, Wize Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Wize Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Wize Pharma?

The current dividend yield of Wize Pharma is .

When does Wize Pharma pay dividends?

Wize Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Wize Pharma?

Wize Pharma paid dividends every year for the past 0 years.

What is the dividend of Wize Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Wize Pharma located?

Wize Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Wize Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Wize Pharma from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Wize Pharma pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Wize Pharma in the year 2023?

In the year 2023, Wize Pharma distributed 0 USD as dividends.

In which currency does Wize Pharma pay out the dividend?

The dividends of Wize Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Wize Pharma

Our stock analysis for Wize Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wize Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.